PFBT
INDV icon

Parkside Financial Bank & Trust’s Indivior Pharmaceuticals INDV Stock Holding History

Parkside Financial Bank & Trust’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.81K Sell
166
-9
-5% -$326 ﹤0.01% 1782
2026
Q1 		$5.33K Sell
175
-156
-47% -$5.15K ﹤0.01% 1798
2025
Q4 		$11.9K Buy
331
+38
+13% +$1.16K ﹤0.01% 1510
2025
Q3 		$7.07K Buy
293
+258
+737% +$5.4K ﹤0.01% 1630
2025
Q2 		$516 Buy
+35
New +$408 ﹤0.01% 2534

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkside Financial Bank & Trust's INDV Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its Indivior Pharmaceuticals (INDV) stake by 5.1% in Q2 2026, selling an estimated $326 and leaving 166 shares worth $6.81K. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

Parkside Financial Bank & Trust first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. The position peaked at $11.9K in Q4 2025. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Parkside Financial Bank & Trust held 166 shares of Indivior Pharmaceuticals worth $6.81K as of Q2 2026.
  • Parkside Financial Bank & Trust sold 9 Indivior Pharmaceuticals shares in Q2 2026, an estimated $326.
  • Indivior Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1782 holding.
  • Parkside Financial Bank & Trust first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Indivior Pharmaceuticals position peaked at $11.9K in Q4 2025.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.